Affimed NV Upside targets 롱

Affimed N.V.NASDAQ

설명

⋅ 2020년 5월 26일 오후 11시 30분

Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.